These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Cytoplasmic estrogen receptor in a pregnancy-dependent mouse mammary tumor (TPDMT-4) and related autonomous lines. Matsuzawa A; Mizuno Y; Yamamoto T; Hori T; Suzuki T Cancer Res; 1980 Sep; 40(9):3361-8. PubMed ID: 7427949 [TBL] [Abstract][Full Text] [Related]
8. Enhanced and reversed growth in vitro of a pregnancy-dependent mouse mammary tumor (TPDMT-4) by a gonadotropin-releasing hormone agonist analog. Matsuzawa A; Yamamoto T Eur J Cancer Clin Oncol; 1982 May; 18(5):495-505. PubMed ID: 6811279 [TBL] [Abstract][Full Text] [Related]
9. A transplantable pregnancy-dependent mammary tumor line (TPDMT-4) in strain DDD mice. Matsuzawa A; Yamamoto T Gan; 1974 Aug; 65(4):307-15. PubMed ID: 4426477 [No Abstract] [Full Text] [Related]
10. Loss of basal cell phenotype with acquisition of lung-colonizing capability in mouse mammary tumors. Tsubura A; Inui T; Morii S; Dairkee SH; Oikawa T; Matsuzawa A Breast Cancer Res Treat; 1991; 17(3):239-43. PubMed ID: 1710155 [TBL] [Abstract][Full Text] [Related]
11. Association of hst gene expression with metastatic phenotype in mouse mammary tumors. Murakami A; Tanaka H; Matsuzawa A Cell Growth Differ; 1990 May; 1(5):225-31. PubMed ID: 1964796 [TBL] [Abstract][Full Text] [Related]
12. Apoptosis of pregnancy-dependent mammary tumor and transplantable pregnancy-dependent mammary tumor in mice. Kojima H; Fukazawa Y; Sato T; Enari M; Matsuzawa A; Tsunoda S; Nagasawa H; Ohta Y; Iguchi T Cancer Lett; 1996 Dec; 110(1-2):113-21. PubMed ID: 9018089 [TBL] [Abstract][Full Text] [Related]
13. Antitumor effect of two oral steroids, mepitiostane and fluoxymesterone, on a pregnancy-dependent mouse mammary tumor (TPDMT-4). Matsuzawa A; Yamamoto T Cancer Res; 1977 Dec; 37(12):4408-15. PubMed ID: 922732 [TBL] [Abstract][Full Text] [Related]
14. Differential response of an ovarian-responsive mouse mammary tumor to androgenic and estrogenic agents. Matsuzawa A; Ikeda Y Cancer Res; 1983 Aug; 43(8):3680-6. PubMed ID: 6861137 [TBL] [Abstract][Full Text] [Related]
15. Pregnancy dependence of mammary tumours in DDD mice congenic for Mtv-2, DDD/1-Mtv-2/Mtv-2. Sayama K; Kaneko T; Matsuzawa A Lab Anim; 1994 Jan; 28(1):44-9. PubMed ID: 8158968 [TBL] [Abstract][Full Text] [Related]
17. Effects of repeated exposure to cyclophosphamide on drug resistance and biological properties of a newly autonomy-acquired mouse mammary tumor (T4-OI320). Takeda Y; Matsuzawa A; Kaneko T; Sekiguchi M; Fujii G Jpn J Exp Med; 1988 Apr; 58(2):87-98. PubMed ID: 2842525 [TBL] [Abstract][Full Text] [Related]
18. Formation of duct-alveolar structures and new types of tumors by a pregnancy-dependent mouse mammary tumor (TPDMT-4) in virgin mice. Matsuzawa A; Kaneko T; Ikeda Y; Yamamoto T Gan; 1982 Jun; 73(3):372-6. PubMed ID: 7129002 [TBL] [Abstract][Full Text] [Related]
19. Enhancement by androgen of the angiogenic ability of androgen-responsive Shionogi carcinoma 115. Takatsuka D; Uchida N; Yamamoto R; Tsuji M; Terada N; Matsumoto K Anticancer Res; 1992; 12(6B):2001-4. PubMed ID: 1284197 [TBL] [Abstract][Full Text] [Related]
20. Inhibited growth in vivo of a mouse pregnancy-dependent mammary tumor (TPDMT-4) by an antiestrogen, 2alpha, 3alpha-epithio-5alpha-androstan-17beta-ol (10275-S). Matsuzawa A; Yamamoto T Cancer Res; 1976 May; 36(5):1598-606. PubMed ID: 178425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]